Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Recombinant DNA Technology market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant DNA Technologymarket, defines the market attractiveness level of Recombinant DNA Technology market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Recombinant DNA Technology industry, describes the types of Recombinant DNA Technology market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant DNA Technology market and the development prospects and opportunities of Recombinant DNA Technology industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant DNA Technology market in Chapter 13.
By Player:
GlaxoSmithKline
GenScript
New England Biolabs
Eli Lilly and Company
Biocon
Cibus
Sanofi
Profacgen
Biogen
Novartis
Monsanto Company
Pfizer Inc
Novo Nordisk
Roche
Merck KGaA
Amgen
Horizon Discovery Group
By Type:
Therapeutic Agent
Vaccine
Biotech Crops
Specialty Chemicals
By End-User:
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Recombinant DNA Technology Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Recombinant DNA Technology Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Recombinant DNA Technology Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Recombinant DNA Technology Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Recombinant DNA Technology Market Analysis and Outlook to 2022
-
7.1 Global Recombinant DNA Technology Consumption (2017-2022)
-
7.2 United States Recombinant DNA Technology Consumption (2017-2022)
-
7.3 Europe Recombinant DNA Technology Consumption (2017-2022)
-
7.4 China Recombinant DNA Technology Consumption (2017-2022)
-
7.5 Japan Recombinant DNA Technology Consumption (2017-2022)
-
7.6 India Recombinant DNA Technology Consumption (2017-2022)
-
7.7 South Korea Recombinant DNA Technology Consumption (2017-2022)
8 Region and Country-wise Recombinant DNA Technology Market Analysis and Outlook to 2028
-
8.1 Global Recombinant DNA Technology Consumption Forecast (2022-2028)
-
8.2 United States Recombinant DNA Technology Consumption Forecast (2022-2028)
-
8.3 Europe Recombinant DNA Technology Consumption Forecast (2022-2028)
-
8.4 China Recombinant DNA Technology Consumption Forecast (2022-2028)
-
8.5 Japan Recombinant DNA Technology Consumption Forecast (2022-2028)
-
8.6 India Recombinant DNA Technology Consumption Forecast (2022-2028)
-
8.7 South Korea Recombinant DNA Technology Consumption Forecast (2022-2028)
9 Global Recombinant DNA Technology Market Outlook by Types and Applications to 2022
-
9.1 Global Recombinant DNA Technology Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Therapeutic Agent Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Vaccine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Biotech Crops Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Specialty Chemicals Consumption and Growth Rate (2017-2022)
-
9.2 Global Recombinant DNA Technology Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Biotechnology and Pharmaceutical Companies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Academic & Government Research Institutes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Recombinant DNA Technology Market Outlook by Types and Applications to 2028
-
10.1 Global Recombinant DNA Technology Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Therapeutic Agent Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Biotech Crops Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Specialty Chemicals Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Recombinant DNA Technology Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Biotechnology and Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Academic & Government Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Recombinant DNA Technology Import and Export Analysis (Top 5 Countries)
-
11.1 Global Recombinant DNA Technology Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Recombinant DNA Technology Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Recombinant DNA Technology Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Recombinant DNA Technology Market Competitive Analysis
-
14.1 GlaxoSmithKline
-
14.1.1 GlaxoSmithKline Company Details
-
14.1.2 GlaxoSmithKline Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmithKline Recombinant DNA Technology Product and Service
-
14.2 GenScript
-
14.2.1 GenScript Company Details
-
14.2.2 GenScript Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GenScript Recombinant DNA Technology Product and Service
-
14.3 New England Biolabs
-
14.3.1 New England Biolabs Company Details
-
14.3.2 New England Biolabs Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 New England Biolabs Recombinant DNA Technology Product and Service
-
14.4 Eli Lilly and Company
-
14.4.1 Eli Lilly and Company Company Details
-
14.4.2 Eli Lilly and Company Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eli Lilly and Company Recombinant DNA Technology Product and Service
-
14.5 Biocon
-
14.5.1 Biocon Company Details
-
14.5.2 Biocon Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Biocon Recombinant DNA Technology Product and Service
-
14.6 Cibus
-
14.6.1 Cibus Company Details
-
14.6.2 Cibus Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Cibus Recombinant DNA Technology Product and Service
-
14.7 Sanofi
-
14.7.1 Sanofi Company Details
-
14.7.2 Sanofi Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sanofi Recombinant DNA Technology Product and Service
-
14.8 Profacgen
-
14.8.1 Profacgen Company Details
-
14.8.2 Profacgen Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Profacgen Recombinant DNA Technology Product and Service
-
14.9 Biogen
-
14.9.1 Biogen Company Details
-
14.9.2 Biogen Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Biogen Recombinant DNA Technology Product and Service
-
14.10 Novartis
-
14.10.1 Novartis Company Details
-
14.10.2 Novartis Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Novartis Recombinant DNA Technology Product and Service
-
14.11 Monsanto Company
-
14.11.1 Monsanto Company Company Details
-
14.11.2 Monsanto Company Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Monsanto Company Recombinant DNA Technology Product and Service
-
14.12 Pfizer Inc
-
14.12.1 Pfizer Inc Company Details
-
14.12.2 Pfizer Inc Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Pfizer Inc Recombinant DNA Technology Product and Service
-
14.13 Novo Nordisk
-
14.13.1 Novo Nordisk Company Details
-
14.13.2 Novo Nordisk Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Novo Nordisk Recombinant DNA Technology Product and Service
-
14.14 Roche
-
14.14.1 Roche Company Details
-
14.14.2 Roche Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Roche Recombinant DNA Technology Product and Service
-
14.15 Merck KGaA
-
14.15.1 Merck KGaA Company Details
-
14.15.2 Merck KGaA Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Merck KGaA Recombinant DNA Technology Product and Service
-
14.16 Amgen
-
14.16.1 Amgen Company Details
-
14.16.2 Amgen Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Amgen Recombinant DNA Technology Product and Service
-
14.17 Horizon Discovery Group
-
14.17.1 Horizon Discovery Group Company Details
-
14.17.2 Horizon Discovery Group Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Horizon Discovery Group Recombinant DNA Technology Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Recombinant DNA Technology
-
Figure Recombinant DNA Technology Picture
-
Table Global Recombinant DNA Technology Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant DNA Technology Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant DNA Technology Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Recombinant DNA Technology Consumption by Country (2017-2022)
-
Figure United States Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Table Europe Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure China Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Japan Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure India Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure South Korea Recombinant DNA Technology Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant DNA Technology Consumption Forecast by Country (2022-2028)
-
Figure United States Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Therapeutic Agent Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Biotech Crops Consumption and Growth Rate (2017-2022)
-
Figure Global Specialty Chemicals Consumption and Growth Rate (2017-2022)
-
Figure Global Biotechnology and Pharmaceutical Companies Consumption and Growth Rate (2017-2022)
-
Figure Global Academic & Government Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Therapeutic Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biotech Crops Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Specialty Chemicals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biotechnology and Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Academic & Government Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Recombinant DNA Technology Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Recombinant DNA Technology Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Recombinant DNA Technology Product and Service
-
Table GenScript (Foundation Year, Company Profile and etc.)
-
Table GenScript Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table GenScript Recombinant DNA Technology Product and Service
-
Table New England Biolabs (Foundation Year, Company Profile and etc.)
-
Table New England Biolabs Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table New England Biolabs Recombinant DNA Technology Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Recombinant DNA Technology Product and Service
-
Table Biocon (Foundation Year, Company Profile and etc.)
-
Table Biocon Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Recombinant DNA Technology Product and Service
-
Table Cibus (Foundation Year, Company Profile and etc.)
-
Table Cibus Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cibus Recombinant DNA Technology Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Recombinant DNA Technology Product and Service
-
Table Profacgen (Foundation Year, Company Profile and etc.)
-
Table Profacgen Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Profacgen Recombinant DNA Technology Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Recombinant DNA Technology Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Recombinant DNA Technology Product and Service
-
Table Monsanto Company (Foundation Year, Company Profile and etc.)
-
Table Monsanto Company Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Monsanto Company Recombinant DNA Technology Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Recombinant DNA Technology Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Recombinant DNA Technology Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Recombinant DNA Technology Product and Service
-
Table Merck KGaA (Foundation Year, Company Profile and etc.)
-
Table Merck KGaA Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck KGaA Recombinant DNA Technology Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Recombinant DNA Technology Product and Service
-
Table Horizon Discovery Group (Foundation Year, Company Profile and etc.)
-
Table Horizon Discovery Group Recombinant DNA Technology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Horizon Discovery Group Recombinant DNA Technology Product and Service
-
